Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., Pelaez, T.·2005·Clinical Infectious Diseases

Cited by (462)

Items 101–200 of 462

  1. Diarrheal Diseases in the Elderly
    Chantri Trinh, Kavita Prabhakar · 2007 · Clinics in Geriatric Medicine
  2. Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science
    Elaine O. Petrof · 2009 · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
  3. Epidemiology of Invasive Fungal Infections in Patients with Acquired Immunodeficiency Syndrome at a Reference Hospital for Infectious Diseases in Brazil
    Renata Buccheri, Jane Harumi Atobe, Simone Aparecida de Souza, Daniel Wagner de Castro Lima Santos · 2014 · Mycopathologia
  4. Risk assessment of fungal materials
    Jeroen G. van den Brandhof, Han A. B. Wösten · 2022 · Fungal Biology and Biotechnology
  5. Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
    Erik R. Dubberke, Philip Carling, Ruth Carrico, Curtis J. Donskey, Vivian G. Loo, L. Clifford McDonald, Lisa L. Maragakis, Thomas J. Sandora, David J. Weber, Deborah S. Yokoe et al. · 2014 · Infection Control and Hospital Epidemiology
  6. Clostridium difficile: controversies and approaches to management
    Martijn P. Bauer, Jaap T. van Dissel, Ed J. Kuijper · 2009 · Current Opinion in Infectious Diseases
  7. Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature
    Serkan Atıcı, Ahmet Soysal, Kıvılcım Karadeniz Cerit, Şerife Yılmaz, Burak Aksu, Gürsu Kıyan, Mustafa Bakır · 2017 · Medical Mycology Case Reports
  8. Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics
    Donald A. MacKenzie, Marianne Defernez, Warwick B. Dunn, Marie Brown, Linda J. Fuller, Santiago Ruiz-Moyano Seco de Herrera, Andreas Günther, Steve A. James, John Eagles, Mark R. Philo et al. · 2008 · Yeast
  9. Genome-wide association analysis of clinical vs. nonclinical origin provides insights into Saccharomyces cerevisiae pathogenesis
    Ludo A. H. Muller, Joseph E. Lucas, D. Ryan Georgianna, John H. McCusker · 2011 · Molecular Ecology
  10. New advances in the treatment of Clostridium difficile infection (CDI)
    Debra Farver · 2008 · Therapeutics and Clinical Risk Management
  11. Probiotics and Liver Disease
    Anish A. Sheth, Guadalupe García–Tsao · 2008 · Journal of Clinical Gastroenterology
  12. Saccharomyces Cerevisiae Fungemia, a Possible Consequence of the Treatment of Clostridium Difficile Colitis with a Probioticum
    Iolanda Santino, A. Alari, S. Bono, Elisabetta Teti, Massimo Marangi, A. Bernardini, Laura Magrini, Salvatore Di Somma, Antonella Teggi · 2014 · International Journal of Immunopathology and Pharmacology
  13. Probiotics and the gastrointestinal tract: Where are we in 2005
    Irit Chermesh · 2006 · World Journal of Gastroenterology
  14. Discovery of Novel Potential Human Targets of Resveratrol by Inverse Molecular Docking
    Katarina Kores, Samo Lešnik, Urban Bren, Dušanka Janežič, Janez Konc · 2019 · Journal of Chemical Information and Modeling
  15. Fungal infections and the fungal microbiome in hepatobiliary disorders
    Phillipp Hartmann, Bernd Schnabl · 2022 · Journal of Hepatology
  16. Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?
    Ronald Lee Koretz · 2018 · The American Journal of Gastroenterology
  17. META-ANALYSIS OF PROBIOTICS FOR THE PREVENTION AND TREATMENT OF ACUTE PEDIATRIC DIARRHEA
    Lynne Vernice McFarland, Gary W. Elmer, Marc Mcfarland · 2006
  18. Rare fungal infectious agents: a lurking enemy
    Anna Skiada, Ioannis Pavleas, Maria Drogari‐Apiranthitou · 2017 · F1000Research
  19. Effects of probiotics on the gastrointestinal tract
    Snelling, Anna M · 2005 · Current Opinion in Infectious Diseases
  20. What next in necrotizing enterocolitis?
    Murat Yurdakök · 2008 · The Turkish Journal of Pediatrics
  21. Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient
    İ. Kara, F. Yıldırım, Ozge Ozgen ., Sidre Erganiş, Müge Aydoğdu, Murat Dizbay, G. Gürsel, Ayşe Kalkancı · 2017 · Journal de Mycologie Médicale
  22. Nutritional Yeast Biomass: Characterization and Application
    Monika Elżbieta Jach, Anna Serefko · 2018 · Elsevier eBooks
  23. Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use
    Mustafa Fadhel, Swapnil Patel, Edward Liu, Michael Levitt, Arif Asif · 2018 · Medical Mycology Case Reports
  24. A Quasi-Domesticate Relic Hybrid Population of Saccharomyces cerevisiae × S. paradoxus Adapted to Olive Brine
    Ana Pontes, Neža Čadež, Paula M. Gonçalves, José Paulo Sampaio · 2019 · Frontiers in Genetics
  25. Anforderungen an die Infektionsprävention bei der medizinischen Versorgung von immunsupprimierten Patienten
    KRINKO · 2021 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  26. Probiotic use in the critically ILL
    Sunit Chandra Singhi, Arun Kumar Baranwal · 2008 · The Indian Journal of Pediatrics
  27. Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021
    Christina C. Chang, Victoria G. Hall, Celia M. Cooper, George Grigoriadis, Justin Beardsley, Tania Christine Sorrell, Christopher H. Heath · 2021 · Internal Medicine Journal
  28. Microsatellite analysis of genetic diversity among clinical and nonclinical Saccharomyces cerevisiae isolates suggests heterozygote advantage in clinical environments
    Ludo A. H. Muller, John H. McCusker · 2009 · Molecular Ecology
  29. A Brief Review of Nutraceutical Ingredients in Gastrointestinal Disorders: Evidence and Suggestions
    Xiang Gao, Jingwen Liu, Li Li, Wei Liu, Meiyan Sun · 2020 · International Journal of Molecular Sciences
  30. Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center
    Soňa Čierniková, Michal Mego, Maria Semanova, Lenka Wachsmannová, Zuzana Adamcikova, Viola Števurková, Ľuboš Drgoňa, Vladimír Zajac · 2016 · Integrative Cancer Therapies
  31. A Case Study of Gut Fermentation Syndrome (Auto-Brewery) with Saccharomyces cerevisiae as the Causative Organism
    Cordell, Barbara, McCarthy, Justin · 2013 · International Journal of Clinical Medicine
  32. Oxidative stress response to menadione and cumene hydroperoxide in the opportunistic fungal pathogen Candida glabrata
    Mayra Cuéllar‐Cruz, Irene Castaño, Omar Elind Arroyo-Helguera, Alejandro De Las Peñas · 2009 · Memórias do Instituto Oswaldo Cruz
  33. The fascination with probiotics for Clostridium difficile infection: Lack of evidence for prophylactic or therapeutic efficacy
    Mark A. Miller · 2009 · Anaerobe
  34. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation
    Rory Michael Shallis, Christopher Terry, Seah H. Lim · 2017 · American Journal of Hematology
  35. A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases
    Bhagavathi Sundaram Sivamaruthi · 2018 · Asian Pacific Journal of Tropical Biomedicine
  36. Do probiotics have a therapeutic role in gastroenterology
    Jimmy K. Limdi · 2006 · World Journal of Gastroenterology
  37. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis
    Zheng‐Yii Lee, Charles Chin Han Lew, Luis Ortiz‐Reyes, Jayshil J. Patel, Yu Jun Wong, Carolyn Tze Ing Loh, Robert G. Martindale, Daren Keith Heyland · 2023 · Clinical Nutrition
  38. Control of nongenetic heterogeneity in growth rate and stress tolerance of Saccharomyces cerevisiae by cyclic AMP-regulated transcription factors
    Shuang Li, Daniella Giardina, Mark L. Siegal · 2018 · PLoS Genetics
  39. Future novel therapeutic agents forClostridium difficileinfection
    Hoonmo L. Koo, Kevin W. Garey, Herbert L. DuPont · 2010 · Expert Opinion on Investigational Drugs
  40. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration
    Arthur Poncelet, Lucien Ruelle, Déborah Konopnicki, Véronique Yvette Miendje Deyi, Nicolás Dauby · 2021 · Infectious Diseases Now
  41. Diversity and antifungal susceptibility of yeasts isolated by multiple-tube fermentation from three freshwater lakes in Brazil
    Luciana R. Brandão, Adriana O. Medeiros, Mariana Costa Duarte, Anne Caroline Barbosa, Carlos A. Rosa · 2009 · Journal of Water and Health
  42. Current evidence on the use of probiotics in liver diseases
    Norberto Carlos Chávez-Tapia, Leticia González-Rodríguez, MinSeung Jeong, Yanine López-Ramírez, Varenka J. Barbero-Becerra, Eva Juárez-Hernández, Juan Luis Romero-Flores, Marco A. Arrese, Nahúm Méndez‐Sánchez, Misael Uribe · 2015 · Journal of Functional Foods
  43. Probiotic-Associated Central Venous Catheter Bloodstream Infections Lead to Increased Mortality in the ICU*
    Scott Mayer, COLIN M BONHAG, Patrick Jenkins, Brendon Cornett, Paula J. Watts, Dmitriy Scherbak · 2023 · Critical Care Medicine
  44. Prevention of Intensive Care Unit-Acquired Pneumonia
    Michael Klompas · 2019 · Seminars in Respiratory and Critical Care Medicine
  45. In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits
    Rosa de Llanos, Silvia Llopis, Gloria Molero, Amparo Querol, Concha Gil, María Teresa Fernández-Espinar · 2010 · International Journal of Food Microbiology
  46. Antimicrobial Therapy of Clostridium difficile-Associated Diarrhea
    Emilio Bouza, Almudena Burillo, Patricia Muñóz · 2006 · Medical Clinics of North America
  47. Management of Clostridium difficile Infection.
    Layth Al-Jashaami, Herbert L. DuPont · 2016 · PubMed Central
  48. Nutrition Support Challenges in Hematopoietic Stem Cell Transplant Patients
    Jennifer L. Thompson, J.K. Duffy · 2008 · Nutrition in Clinical Practice
  49. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Maria J. G. T. Vehreschild, Jörg Janne Vehreschild, Kai Hübel, Marcus Hentrich, Martin Schmidt‐Hieber, Maximilian Christopeit, Georg Maschmeyer, Enrico Schalk, Oliver A. Cornely, S. Neumann · 2013 · Annals of Oncology
  50. Clinical characteristics and risk factors of non-Candida fungaemia
    Masaki Yamamoto, Shunji Takakura, Gou Hotta, Yasufumi Matsumura, Aki Matsushima, Miki Nagao, Yutaka Ito, Satoshi Ichiyama · 2013 · BMC Infectious Diseases
  51. Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals
    Daniel A. Caroff, Deborah S. Yokoe, Michael Klompas · 2017 · Clinical Infectious Diseases
  52. Identification and Molecular Analysis of Pathogenic Yeasts in Droppings of Domestic Pigeons in Beijing, China
    Yuan Wu, Pengcheng Du, Wenge Li, Jinxing Lu · 2012 · Mycopathologia
  53. Population genomics reveals evolution and variation of Saccharomyces cerevisiae in the human and insects gut
    Matteo Ramazzotti, Irene Stefanini, Monica Di Paola, Carlotta De Filippo, Lisa Rizzetto, Luisa Berná, Leonardo Dapporto, Damaríz Rivero, Noemi Tocci, Tobias Weil et al. · 2018 · Environmental Microbiology
  54. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient
    María Fernanda Landaburu, Gabriela López Daneri, Silvia Relloso, Leandro Jorge Zarlenga, Mónica Alejandra Vinante, María Teresa Mujica · 2019 · Revista Argentina de Microbiología
  55. Rare Invasive Yeast Infections in Greek Neonates and Children, a Retrospective 12-Year Study
    Maria Noni, Angeliki Stathi, Aristea Velegraki, Mika Malamati, Alexandra Kalampaliki, Levantia Zachariadou, Athanasios G. Michos · 2020 · Journal of Fungi
  56. Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement
    Thomas E. Ichim, Santosh Kesari, Kim Shafer · 2018 · Oncotarget
  57. Probiotic Use and Prevalence of Candidemia and Candiduria in a PICU
    Suresh Kumar, Sunit Chandra Singhi, Arunloke Chakrabarti, Arun Bansal, Muralidharan Jayashree · 2013 · Pediatric Critical Care Medicine
  58. Gut immune homeostasis: the immunomodulatory role of Bacillus clausii , from basic to clinical evidence
    Rosa María Wong‐Chew, Jo-Anne A. de Castro, Lorenzo Morelli, Marcos III Perez, Metehan Özen · 2022 · Expert Review of Clinical Immunology
  59. Recurrent Clostridium difficile Infection
    Claire van Nispen tot Pannerden, Annelies Verbon, Ernst Johan Kuipers · 2011 · Drugs
  60. Safety of Probiotic Bacteria
    Mohammad Reza Abdollahi, Amir Hossein Abdolghaffari, Maziar Gooshe, Seyedeh Farnaz Ghasemi‐Niri · 2015 · Elsevier eBooks
  61. Gut Mycobiota and Fungal Metabolites in Human Homeostasis
    Izabella Mogilnicka, Marcin Ufnal · 2018 · Current Drug Targets
  62. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections
    Jon Salmanton‐García, Philipp A. Koehler, Anupma Jyoti Kindo, Iker Falces‐Romero, Julio García‐Rodríguez, Zdeněk Ráčil, Sharon C.‐A. Chen, Н Н Климко, Guillaume Désoubeaux, George R. Thompson et al. · 2020 · Journal of Infection
  63. The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial.
    Homayoun Zojaji, Mehdi Ghobakhlou, Hassan Rajabalinia, Elnaz Ataei, Somayeh Jahani Sherafat, Bijan Moghimi-Dehkordi, Rasoul Bahreiny · 2013 · Gastroenterology and hepatology from bed to bench.
  64. Clostridium difficileColitis: A Review
    Varsha V. Moudgal, Jack D. Sobel · 2012 · Hospital Practice
  65. Effects of complex probiotic supplementation in growing pig diets with and without palm kernel expellers on growth performance, nutrient digestibility, blood parameters, fecal microbial shedding and noxious gas emission
    Wen‐Chao Liu, Subramaniam Mohana Devi, Jaewon Park, In Ho Kim · 2017 · Animal Science Journal
  66. Bugs or drugs: Are probiotics safe for use in the critically ill?
    Urben, Lindsay M., Wiedmar, Jennifer, Boettcher, Erica, Cavallazzi, Rodrigo, Martindale, Robert G., McClave, Stephen A. · 2014 · Current Gastroenterology Reports
  67. A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial
    Ke Gong Chen, J. Xin, G. Zhang, Hui Wen Xie, Li Luo, S. Yuan, Y. Bu, X. Yang, Y. Ge, Changqi Liu · 2020 · Beneficial Microbes
  68. Pathogenic Potential of Saccharomyces Strains Isolated from Dietary Supplements
    Silvia Llopis, Carolina Hernández‐Haro, Lucía Monteoliva, Amparo Querol, Marı́a Molina, María Teresa Fernández-Espinar · 2014 · PLoS ONE
  69. How to: prophylactic interventions for prevention of Clostridioides difficile infection
    Elena Reigadas, Joffrey van Prehn, Marco Falcone, Fidelma Fitzpatrick, Maria J. G. T. Vehreschild, Ed J. Kuijper, Emilio Bouza · 2021 · Clinical Microbiology and Infection
  70. Quantitative real time PCR assays for the enumeration of Saccharomyces cerevisiae and the Saccharomyces sensu stricto complex in human feces
    Ho-Won Chang, Young‐Do Nam, Youlboong Sung, Kyoung‐Ho Kim, Seong Woon Roh, Jung‐Hoon Yoon, Kwang‐Guk An, Jin‐Woo Bae · 2007 · Journal of Microbiological Methods
  71. A Review of the Economics of Treating Clostridium difficile Infection
    Kari A. Mergenhagen, Amy L. Wojciechowski, Joseph A. Paladino · 2014 · PharmacoEconomics
  72. Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives
    Ivana Cibulková, Veronika Řehořová, Jan Hajer, František Duška · 2021 · Biomolecules
  73. The Flo Adhesin Family
    Ronnie Willaert, Yeseren Kayacan, Bart V. Devreese · 2021 · Pathogens
  74. mDrop-Seq: Massively Parallel Single-Cell RNA-Seq of Saccharomyces cerevisiae and Candida albicans
    Ryan Dohn, Bingqing Xie, Rebecca Back, Alan Selewa, Heather Eckart, Reeta P. Rao, Anindita Basu · 2021 · Vaccines
  75. Pharmacotherapy of yeast infections
    Alicia Gómez‐López, Óscar Zaragoza, Juan L. Rodrı́guez-Tudela, Manuel Cuenca‐Estrella · 2008 · Expert Opinion on Pharmacotherapy
  76. Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial
    Stephen B. Freedman, Sarah Williamson-Urquhart, Suzanne Schuh, Philip M. Sherman, Ken J. Farion, Serge Gouin, Andrew R. Willan, Ron A. Goeree, David W. Johnson, Karen J. L. Black et al. · 2014 · Trials
  77. Epidemiology and Antifungal Susceptibilities of Yeast Isolates Causing Invasive Infections Across Urban Beijing, China
    Lina Guo, Meng Xiao, Bin Cao, Fen Qu, Yuliang Zhan, Yunjian Hu, Xinru Wang, Guowei Liang, Haitong Gu, Jun Qi et al. · 2017 · Future Microbiology
  78. New Nutritional and Therapeutical Strategies of NEC
    Teresa Capriati, Antonella Diamanti, de Ville de Goyet Jean · 2019 · Current Pediatric Reviews
  79. Current and future developments in travelers’ diarrhea therapy
    Hoonmo L. Koo, Herbert L. DuPont · 2006 · Expert Review of Anti-infective Therapy
  80. The management of Clostridium difficile infection
    O. Martin Williams, R.C. Spencer · 2009 · British Medical Bulletin
  81. Prevalence and susceptibility of Saccharomyces cerevisiae causing vaginitis in Greek women
    Virginia Papaemmanouil, N Georgogiannis, M. Plega, J. Lalaki, D. Lydakis, M. Dimitriou, Apollon Papadimitriou · 2011 · Anaerobe
  82. Hospital-related outbreaks due to rare fungal pathogens: a review of the literature from 1990 to June 2011
    Ernestina Carla Repetto, Claudio Giacomazzi, Francesco Castelli · 2012 · European Journal of Clinical Microbiology & Infectious Diseases
  83. Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
    Beata Sulik‐Tyszka, Emilian Snarski, Magda Niedźwiedzka, Małgorzata Augustyniak, Thorvald Nilsen Myhre, Anna Kacprzyk, Ewa Swoboda‐Kopeć, Marta Roszkowska, Jadwiga Dwilewicz‐Trojaczek, W Wiktor-Jędrzejczak et al. · 2017 · Probiotics and Antimicrobial Proteins
  84. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options
    Masako Mizusawa, Shira Doron, Sherwood L. Gorbach · 2015 · Drugs & Aging
  85. Infections caused by non- Candida , non- Cryptococcus yeasts
    Michael A. Pfaller, Daniel J. Diekema, William G. Merz · 2009 · Elsevier eBooks
  86. Role of probiotics in prevention of Candida infection in critically ill children
    Suresh Kumar, Sunit Chandra Singhi · 2012 · Mycoses
  87. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease
    Lanxia Meng, Congcong Liu, Yiming Li, Guiqin Chen, Min Xiong, Ting Yu, Lina Pan, Xingyu Zhang, Lingyan Zhou, Tao Guo et al. · 2023 · Science Advances
  88. Probiotics and Coronavirus disease 2019: think about the link
    Suresh Kumar Angurana, Arun Bansal · 2020 · British Journal Of Nutrition
  89. [Lactic Acid Bacteria] Probiotic Lactic Acid Bacteria
    Yong-Geun Ann · 2011 · The Korean Journal of Food And Nutrition
  90. Effect of oxidative stress on cell wall morphology in four pathogenic Candida species
    Mayra Denisse Ramírez-Quijas, Roberto Zazueta‐Sandoval, Armando Obregón-Herrera, Everardo López-Romero, Mayra Cuéllar‐Cruz · 2015 · Mycological Progress
  91. Probiotics in the Treatment of Acute Diarrhea in Young Children
    Toktam Moghiman, Farahzad Jabbari, Hamid Ahanchian, Reza Farid, Hamid Reza Kianifar, Armin Sistanian · 2009 · DOAJ (DOAJ: Directory of Open Access Journals)
  92. Clinical Saccharomyces cerevisiae isolates cannot cross the epithelial barrier in vitro
    Roberto Pérez‐Torrado, Silvia Llopis, Lene Jespersen, María Teresa Fernández-Espinar, Amparo Querol · 2012 · International Journal of Food Microbiology
  93. Risk of Clostridium difficile Infection in Hospitalized Patients Receiving Metronidazole for a Non–C difficile Infection
    Sandra Rodriguez, Marlow B. Hernandez, Giorgio Tarchini, Megan Zaleski, Marjon Vatanchi, Lyssette L Cardona, Fernando Castro, Alison Schneider · 2014 · Clinical Gastroenterology and Hepatology
  94. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic
    Eric Wombwell, Bridget A. Bransteitter, Lisa R. Gillen · 2021 · Mycoses
  95. The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction—A systematic review
    Saiko Sugita, Peggy Tahir, Sakura Kinjo · 2023 · PLoS ONE
  96. Two Cases of Vaginitis Caused by Itraconazole-Resistant Saccharomyces cerevisiae and a Review of Recently Published Studies
    Vincenzo Savini, Chiara Catavitello, Assunta Manna, Marzia Talia, Fabio Febbo, Andrea Balbinot, F. D’Antonio, Giovanni Di Bonaventura, Claudio Celentano, Marco Liberati et al. · 2008 · Mycopathologia
  97. Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification
    Hans Duyvejonck, Piet Cools, Johan M. A. Decruyenaere, Kristien Roelens, Lucien A. Noens, Stefan J. T. Vermeulen, Geert Claeys, Ellen Decat, Els Van Mechelen, Mario Vaneechoutte · 2015 · PLoS ONE
  98. Infección fúngica invasora en el paciente crítico: diferentes opciones terapéuticas y una misma estrategia
    Rafael Zaragoza, Javier Pemán · 2006 · Revista Iberoamericana de Micología
  99. Safety of Probiotics in Health and Disease
    Daliri, Eric Banan-Mwine, Lee, Byong H., Oh, Deog H. · 2019 · The Role of Functional Food Security in Global Health
  100. Preliminary evaluation of the safety and efficacy of oral human antimicrobial peptide LL-37 in the treatment of patients of COVID-19, a small-scale, single-arm, exploratory safety study
    Hanlin Zhang, Yiming Zhao, Xiaoxiao Jiang, Yuying Zhao, Yang Li, Li Chen, Meng Dong, Zhe Luan, Chunlong Yan, Jianwei Jiao et al. · 2020 · medRxiv